Barinthus Biotherapeutics (BRNS)

• Market cap: $28.8M
• 1 day: -5.06%
• 5 days: -1.07%
• 1 month: -0.72%
• 3 months: -40.76%
• 6 months: -46.18%
• Year to date: -4.08%
• 1 year: -29.5%
• 5 years: -95%
• 10 years: -95%
• Sector: Healthcare
• Industry: Biotechnology

About: Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.

Employees: 105